Planned Solutions’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,145
Closed -$132K 459
2024
Q3
$132K Buy
+1,145
New +$130K 0.05% 166
2024
Q1
Sell
-310
Closed -$31.3K 394
2023
Q4
$31.3K Buy
+310
New +$29.9K 0.01% 339

Other funds holding NVS

Planned Solutions's NVS Position: Q4 2024 in Review

Planned Solutions sold out of Novartis (NVS) in Q4 2024, closing a stake of 1,145 shares — an estimated $132K sold.

Planned Solutions first reported a position in NVS in Q4 2023 and held it in 2 quarters. The position peaked at $132K in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Planned Solutions reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 1,145 Novartis shares in Q4 2024, an estimated $132K.
  • Planned Solutions first reported a position in Novartis in Q4 2023 and held it in 2 quarters.
  • Planned Solutions's Novartis position peaked at $132K in Q3 2024.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.